ForFarmers Future Growth
Future criteria checks 3/6
ForFarmers is forecast to grow earnings and revenue by 21.3% and 1.6% per annum respectively. EPS is expected to decline by 48.6% per annum. Return on equity is forecast to be 4.3% in 3 years.
Key information
21.3%
Earnings growth rate
-48.6%
EPS growth rate
Food earnings growth | 10.1% |
Revenue growth rate | 1.6% |
Future return on equity | 4.3% |
Analyst coverage | Low |
Last updated | 01 Nov 2024 |
Recent future growth updates
Recent updates
ForFarmers (AMS:FFARM) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Aug 16Here's Why ForFarmers (AMS:FFARM) Has A Meaningful Debt Burden
May 03ForFarmers (AMS:FFARM) Has Announced That Its Dividend Will Be Reduced To €0.15
Mar 08ForFarmers (AMS:FFARM) Could Be Struggling To Allocate Capital
Jul 16ForFarmers (AMS:FFARM) Has Affirmed Its Dividend Of €0.29
Apr 13ForFarmers (AMS:FFARM) Has Announced A Dividend Of €0.29
Feb 27We Think ForFarmers (AMS:FFARM) Can Stay On Top Of Its Debt
Nov 30ForFarmers (AMS:FFARM) Could Be Struggling To Allocate Capital
Aug 19Is ForFarmers (AMS:FFARM) A Risky Investment?
May 10Tread With Caution Around ForFarmers N.V.'s (AMS:FFARM) 4.9% Dividend Yield
Apr 04What Type Of Returns Would ForFarmers'(AMS:FFARM) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Mar 16Are Investors Undervaluing ForFarmers N.V. (AMS:FFARM) By 45%?
Mar 01Here's Why ForFarmers's (AMS:FFARM) Statutory Earnings Are Arguably Too Conservative
Feb 01Does ForFarmers N.V.'s (AMS:FFARM) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?
Jan 15What To Know Before Buying ForFarmers N.V. (AMS:FFARM) For Its Dividend
Dec 28We Think ForFarmers (AMS:FFARM) Can Manage Its Debt With Ease
Dec 15If You Had Bought ForFarmers' (AMS:FFARM) Shares Three Years Ago You Would Be Down 47%
Dec 01Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,833 | 28 | 38 | 80 | 2 |
12/31/2025 | 2,815 | 27 | 41 | 80 | 2 |
12/31/2024 | 2,754 | 18 | 51 | 46 | 2 |
6/30/2024 | 2,724 | 17 | 60 | 91 | N/A |
3/31/2024 | 2,849 | 8 | 56 | 89 | N/A |
12/31/2023 | 2,975 | -1 | 52 | 87 | N/A |
9/30/2023 | 3,149 | -4 | 47 | 82 | N/A |
6/30/2023 | 3,324 | -7 | 43 | 78 | N/A |
3/31/2023 | 3,320 | 5 | 28 | 63 | N/A |
12/31/2022 | 3,315 | 18 | 13 | 48 | N/A |
9/30/2022 | 3,134 | 15 | 7 | 42 | N/A |
6/30/2022 | 2,953 | 13 | 1 | 37 | N/A |
3/31/2022 | 2,812 | 12 | 8 | 46 | N/A |
12/31/2021 | 2,671 | 12 | 15 | 55 | N/A |
9/30/2021 | 2,582 | 9 | 33 | 74 | N/A |
6/30/2021 | 2,494 | 5 | 50 | 93 | N/A |
3/31/2021 | 2,423 | 10 | 56 | 96 | N/A |
12/31/2020 | 2,352 | 14 | 62 | 98 | N/A |
9/30/2020 | 2,357 | 21 | 68 | 102 | N/A |
6/30/2020 | 2,361 | 28 | 74 | 106 | N/A |
3/31/2020 | 2,412 | 23 | 67 | 101 | N/A |
12/31/2019 | 2,463 | 18 | 59 | 96 | N/A |
9/30/2019 | 2,500 | 25 | 31 | 71 | N/A |
6/30/2019 | 2,537 | 33 | 2 | 47 | N/A |
3/31/2019 | 2,471 | 46 | 20 | 64 | N/A |
12/31/2018 | 2,405 | 59 | 38 | 82 | N/A |
9/30/2018 | 2,327 | 61 | 62 | 101 | N/A |
6/30/2018 | 2,250 | 63 | 86 | 120 | N/A |
3/31/2018 | 2,234 | 61 | N/A | 118 | N/A |
12/31/2017 | 2,219 | 59 | N/A | 116 | N/A |
9/30/2017 | 2,184 | 59 | N/A | 99 | N/A |
6/30/2017 | 2,149 | 59 | N/A | 81 | N/A |
3/31/2017 | 2,129 | 56 | N/A | 81 | N/A |
12/31/2016 | 2,109 | 53 | N/A | 81 | N/A |
9/30/2016 | 2,152 | 52 | N/A | 73 | N/A |
6/30/2016 | 2,195 | 51 | N/A | 65 | N/A |
3/31/2016 | 2,220 | 51 | N/A | 63 | N/A |
12/31/2015 | 2,244 | 51 | N/A | 62 | N/A |
9/30/2015 | 2,164 | 52 | N/A | N/A | N/A |
6/30/2015 | 2,125 | 54 | N/A | N/A | N/A |
3/31/2015 | 2,173 | 51 | N/A | N/A | N/A |
12/31/2014 | 2,221 | 48 | N/A | 79 | N/A |
9/30/2014 | 2,303 | 41 | N/A | N/A | N/A |
6/30/2014 | 2,426 | 34 | N/A | N/A | N/A |
3/31/2014 | 2,491 | 33 | N/A | N/A | N/A |
12/31/2013 | 2,472 | 31 | N/A | 55 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FFARM's forecast earnings growth (21.3% per year) is above the savings rate (1.2%).
Earnings vs Market: FFARM's earnings (21.3% per year) are forecast to grow faster than the Dutch market (15.7% per year).
High Growth Earnings: FFARM's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: FFARM's revenue (1.6% per year) is forecast to grow slower than the Dutch market (8.8% per year).
High Growth Revenue: FFARM's revenue (1.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: FFARM's Return on Equity is forecast to be low in 3 years time (4.3%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 01:16 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ForFarmers N.V. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Maarten Bakker | ABN AMRO Bank N.V. |
Fernand de Boer | Degroof Petercam |
Christophe Beghin | Kempen & Co. NV |